Cannabis
Global Seeks to Rewrite THC Cost and Bioavailability via Inclusion
of THC Under Provisional Patent Filed Nanotechnology
Program
LOS
ANGELES, CA -- October 20, 2020 -- InvestorsHub NewsWire --
Cannabis Global, Inc. (OTC:
CBGL) ("Cannabis Global" or the "Company"), a cannabinoid and
hemp extract science-forward company developing unique infusion
technologies and products, today announces the addition of
Tetrahydrocannabinol (THC) to its Project Varin research program,
in partnership with Natural Plant Extract of California, Inc
("NPE"), a licensed and regulated cannabis products
manufacturer. The Company's goal is to demonstrate the cost
advantages of using its proprietary and provisional patent pending
nanoparticle and nanofiber technologies to significantly change the
cost model relating to the addition of THC to consumer
products.
"Our
goal with THC and Project Varin is simple: delivering to the
cannabis industry a better form of THC that is substantially more
effective, less expensive, and free of the potentially dangerous
chemicals used in currently available formulations. Over the
past few months, our research program has made substantial progress
toward these goals with strong successes in CBD,
Tetrahydrocannabivarin (THC-V), and Cannabinol (CBN). By
applying what we have learned thus far to THC, we hope to formulate
an entirely new class of THC product for the cannabis industry that
will be included under our nanotechnology provisional patent filing
and future patent applications," commented Company CEO, Arman
Tabatabaei.
Last
year, Cannabis Global filed six provisional patent applications,
one of which outlined the methods and end product of technologies
to create new forms of polymeric cannabinoid nanoparticles.
Since the nanoparticle filing, the Company has expanded its
research to include several of the lesser-known cannabinoids, such
as Tetrahydrocannabivarin (THC-V) and Cannabinol (CBN). The
Company plans to add Tetrahydrocannabinol (THC) to the program with
the aim of creating new particles and fibers that will allow
product formulators and manufacturers to use a fraction of the
active ingredient while providing superior effectiveness for
consumers.
The
Company's addition of THC to Project Varin will be performed in
conjunction with Natural Plant Extract of California, Inc. ("NPE"),
which operates a licensed cannabis manufacturing and distribution
business operation out of Lynwood, California. NPE owns a Type 7
California Manufacturing License as well as a California
Distribution license. The Company recently announced an
agreement to purchase (18.8%) of Natural Plant Extract's
outstanding capital stock.
Mr.
Tabatabaei added, "What we have achieved in only one year relative
to the production of cannabinoids containing nanofibers and
particles is unique. While the current state of the art for
cannabinoid nanotechnology relies on a variety of chemicals to load
particles and fibers at approximately 13% of active ingredients, we
have invented methods to create loaded particles at over 50% in
both ultra-fast acting and sustained-release formats.
Currently available technologies add unacceptable tastes and odors
due to the use of chemicals. Our formulations are free of
surfactants, emulsifiers, and similar chemicals. The
addition of THC to our program adds significant value to our
intellectual property portfolio, and will be a strong addition to
our upcoming patent filings."
The use
of nanotechnologies in the cannabis industry is not new, with many
licensed dispensaries and delivery services offering
products. Consumers often prefer the nano-enhanced version of
products due to the increased psychoactive effect; such products,
however, are expensive to manufacturer and are loaded with
significant amounts of chemical surfactants, emulsifiers, and other
additives, which may not be healthy and usually added very
unpleasant flavors to foods and beverages. The Company's
technologies are designed to produce cannabinoids that offer vastly
different properties that are free of surfactants, emulsifiers, and
similar chemicals.
About
Cannabis Global, Inc.
Cannabis
Global, Inc., formerly known as MCTC Holdings, Inc., is a fully
audited and reporting Company with the U.S. Securities &
Exchange Commission, trading with the stock symbol
CBGL. The Company is an emerging force in the area of
cannabinoid sciences and highly bioavailable hemp and cannabis
infusion technologies. The Company has an actively growing
portfolio of intellectual property having filed six patents in the
areas of cannabinoid delivery systems and cannabinoid polymeric
nanoparticles. The Company markets its consumer products under the
Hemp You Can Feel™ brand name. Cannabis Global launched its Project
Varin early in 2020, to develop new delivery methods for rare
cannabinoid Tetrahydrocannabivarin (THV-C) and to develop products
based on this cannabinoid.
About
Provisional Patent Filings
Under
United States patent law, a provisional application is a legal
document filed in the United States Patent and Trademark Office,
that establishes an early filing date, but does not mature into an
issued patent unless the applicant files a regular non-provisional
patent application within one year.
Psychoactive
Cannabis and Federal Law
Psychoactive
Cannabis containing more than 0.3% THC is a Schedule 1 controlled
substance and is illegal under federal law, specifically the
Controlled Substances Act (21 U.S.C. § 811). Even in states that
have legalized the use of psychoactive cannabis for medical and/or
recreational use, its sale and use remain violations of federal
law. The illegality of psychoactive cannabis under federal law
preempts state laws that legalize its use. Strict enforcement of
federal law regarding psychoactive cannabis would materially impact
our business.
Forward-looking
Statements
This
news release contains "forward-looking statements" which are not
purely historical and may include any statements regarding beliefs,
plans, expectations or intentions regarding the future. Such
forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based products. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-k, our quarterly reports
on Form 10-Q and other periodic reports filed from time-to-time
with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For
more information, please contact:
Arman
Tabatabaei
IR@cannabisglobalinc.com
+1-(310)-986-4929
Public
Relations:
Tiger
Global Marketing & Branding Agency
info@TigerGMP.com
www.TigerGMP.com
SOURCE
Cannabis Global, Inc.
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Oct 2023 to Oct 2024
